Term Name: | cidofovir anhydrous |
---|---|
Synonyms: | (S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid, (S)-1-(3-hydroxy-2-phosphonomethoxypropyl)cytosine, (S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, (S)-HPMPC, ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid, 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, 1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, [(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid, CDV, Cidofovir, Cidofovir anhydrous |
Definition: | Cytosine substituted at the 1 position by a 3-hydroxy-2-(phosphonomethoxy)propyl group (S configuration). A nucleoside analogue, it is an injectable antiviral used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. |
Ontology: | ChEBI [CHEBI:3696] ( EBI ) |